logo-loader
viewAllergan

Allergan plc, Moleculin Biotech Inc, Estee Lauder Companies Inc, Abercrombie & Fitch Co - PRE-MARKET

Biotech stocks were in play before the bell in New York ..

1509540820_Botox_376962886.jpg
Allergan makes botox

US stock futures are showing a higher open, and a number of stocks are in play in pre-market deals.

Biotech and drugs appear to be a focus with Allergan plc  (NYSE:AGN) added 1.03% pre-market to US$179.05 despite the botox maker reported a third quarter loss of US$4.03bn, compared to a profit in the same time last year

The results, however,  topped Wall Street expectations.

Moleculin Biotech Inc (NASDAQ:MBRX) up 8.81% to US$2.10 ahead of the bell.

It comes as the firm disclosed that MD Anderson filed IND with the FDA for WP1066 for the treatment of brain tumors

Elsewhere, United States Steel Corporation (NYSE:X) added 10.39% to US$27.95 after the firm reported upbeat earnings for its third quarter.

Elsewhere, Abercrombie & Fitch Co (NYSE:ANF) lost 8.79% to US$12.25 each after falling 1.54% yesterday.

Perfume and fashion group Estee Lauder Companies Inc (NYSE:EL) shares zoomed up 8.22% to US$121 after it topped Wall Street expectations for its first quarter.

Quick facts: Allergan

Price: - -

NYSE:AGN
Market: NYSE
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

SkinBioTherapeutics assessing options for a 'rapid trial' of its food supplement

SkinBioTherapeutics PLC (LON:SBTX) CEO Stuart Ashman tells Proactive London's Andrew Scott they're looking at all routes possible to get its psoriasis product into the hands of those that need it as they assesses options for a fast-track human study. It's part of their collaboration with...

1 hour, 53 minutes ago

2 min read